IL-31 for Canine Atopic Dermatitis

Zoetis has been granted conditional release of their Canine Atopic Dermatitis Immunotherapeutic monoclonal antibody against IL-31. This injection has been developed for managing pruritus in dogs by binding their IL-31 with a monoclonal antibody. Like Apoquel (oclacitinib), it has the potential to reduce pruritus within 24 to 48 hours with a single subcutaneous injection lasting up to 3 to 6 weeks depending on the dose and responsiveness of the patient. Approximately 90% of patients respond…

Read More

Using Bravecto for Treating Demodex in Dogs

The oral flea and tick preventives, Bravecto, NexGard, and Simparica, have been evaluated for their efficacy against Demodex canis. When the normal flea and tick preventative dose is administered as directed an excellent response against Demodex canis mites has been reported in peer reviewed journals. Concurrent therapy with oral ivermectin is not contraindicated but should not be required. Most treated patients should resolve their demodicosis within a few months of therapy. A recently published Journal…

Read More